Trace elements as tumor biomarkers and prognostic factors in breast cancer: A study through energy dispersive x-ray fluorescence

BMC Research Notes

Volumn 5, Issue , 2012, Pages

  Silva, Marina P ^a   Soave, Danilo F ^a   Ribeiro Silva, Alfredo ^a   Poletti, Martin E ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; COPPER; IRON; TRACE ELEMENT; TUMOR MARKER; ZINC;

ADULT; AGED; ARTICLE; BREAST TUMOR; FEMALE; HUMAN; KAPLAN MEIER METHOD; METABOLISM; METHODOLOGY; MIDDLE AGED; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; REFERENCE VALUE; SPECTROMETRY;

ADULT; AGED; BREAST NEOPLASMS; CALCIUM; COPPER; FEMALE; HUMANS; IRON; KAPLAN-MEIER ESTIMATE; MIDDLE AGED; PROGNOSIS; REFERENCE VALUES; ROC CURVE; SPECTROMETRY, X-RAY EMISSION; TRACE ELEMENTS; TUMOR MARKERS, BIOLOGICAL; ZINC;

EID: 84862190674     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-5-194     Document Type: Article

References (76)

1. Prognostic factors in breast cancer-College of American Pathologists Consensus Statement 1999. Fitzgibbons PL, Page DL, Weaver D, Thor AD, Allred C, Clark GM, Ruby SC, OMalley F, Sinpson LF, Connolly JL, et al. Arch Pathol Lab Med 2000 124 7 966 978 10888772
2. Human-Breast Cancer-Correlation of Relapse and Survival with Amplification of the Her-2 Neu Oncogene. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL, Science 1987 235 4785 177 182 10.1126/science.3798106 3798106 (Pubitemid 17231334)
3. Prognostic Value of Vascular Endothelial Growth Factor in Breast Cancer. Gasparini G, Oncologist 2000 5 suppl 1 37 44 10804090 (Pubitemid 30225456)
4. Accumulation of P53 Tumor Suppressor Gene Protein-an Independent Marker of Prognosis in Breast Cancers. Thor AD, Moore DH, Edgerton SM, Kawasaki ES, Reihsaus E, Lynch HT, Marcus JN, Schwartz L, Chen LC, Mayall BH, et al. J Natl Cancer Inst 1992 84 11 845 855 10.1093/jnci/84.11.845 1317462
5. Emerging Biomarkers and New Understanding of Traditional Markers in Personalized Therapy for Breast Cancer. Dowsett M, Dunbier AK, Clin Cancer Res 2008 14 24 8019 8026 10.1158/1078-0432.CCR-08-0974 19088018
6. Opinion-Shaping the future of biomarker research in breast cancer to ensure clinical relevance. Hinestrosa MC, Dickersin K, Klein P, Mayer M, Noss K, Slamon D, Sledge G, Visco FM, Nat Rev Cancer 2007 7 4 309 315 10.1038/nrc2113 17384585 (Pubitemid 46480973)
7. Determination of Ca, Fe, Cu and Zn and their correlations in breast cancer and normal adjacent tissues. Silva MP, Tomal A, Perez CA, Ribeiro-Silva A, Poletti ME, X-Ray Spectrom 2009 38 2 103 111 10.1002/xrs.1126
8. Rose J, Trace Elements in Health Butterworth-Heinemann, London 1983
9. Prasad AS, Oberleas D, Trace Elements in Human Health and Disease Academic, New York 1976
10. Prasad A, Trace Elements and iron in human metabolism J. Wiley, New York 1978
11. Sigel H, Metal Ions in Biological Systems: Carcinogenicity and Metal Ions Marcel Dekker, Inc., New York 1980
12. Trace-Metal Levels in Cancer of Breast. Santoliquido PM, Southwick HW, Olwin JH, Surg Gynecol Obstet 1976 142 1 65 70 1244691
13. Comparison between Concentrations of Trace-Elements in Normal and Neoplastic Human-Breast Tissue. Rizk SL, Skypeck HH, Cancer Res 1984 44 11 5390 5394 6488192 (Pubitemid 15204516)
14. Microcalcifications associated with breast cancer: An epiphenomenon or biologically significant feature of selected tumors? Morgan MP, Cooke MM, McCarthy GM, J Mammary Gland Biol Neoplasia 2005 10 2 181 187 10.1007/s10911-005-5400-6 16025224 (Pubitemid 41031007)
15. Calcium hydroxyapatite promotes mitogenesis and matrix metalloproteinase expression in human breast cancer cell lines. Morgan MP, Cooke MM, Christopherson PA, Westfall PR, McCarthy GM, Mol Carcinog 2001 32 3 111 117 10.1002/mc.1070 11746823 (Pubitemid 33055000)
16. Iron and Neoplasia. Weinberg ED, Biological Trace Element Research 1981 3 1 55 80 10.1007/BF02789123 (Pubitemid 11033427)
17. Iron and iron-related parameters in oncology. Konemann S, Bolling T, Matzkies F, Willich N, Kisters K, Micke O, Trace Elem Electrolytes 2005 22 2 142 149 (Pubitemid 40637960)
18. Role of copper in tumour angiogenesis-clinical implications. Nasulewiez A, Mazur A, Opolski A, J Trace Elem Med Biol 2004 18 1 1 8 10.1016/j.jtemb.2004. 02.004 15487757 (Pubitemid 39285958)
19. Does excess iron play a role in breast carcinogenesis? an unresolved hypothesis. Kabat GC, Rohan TE, Cancer Causes Control 2007 18 10 1047 1053 10.1007/s10552-007-9058-9 17823849 (Pubitemid 47498168)
20. Iron-induced carcinogenesis: The role of redox regulation. Toyokuni S, Free Radic Biol Med 1996 20 4 553 566 10.1016/0891-5849(95)02111-6 8904296 (Pubitemid 26097272)
21. Discriminant analysis of trace elements in normal, benign and malignant breast tissues measured by total reflection X-ray fluorescence. da Silva MP, Zucchi O, Ribeiro-Silva A, Poletti ME, Spectroc Acta Pt B-Atom Spectr 2009 64 6 587 592 10.1016/j.sab.2009.05.026
22. A preliminary study of the distribution of trace elements in healthy and neoplastic breast tissues with synchrotron radiation X-ray fluorescence. Poletti ME, Goncalves OD, Perez CA, Magalhaes SD, Radiat Phys Chem 2004 71 3-4 975 976 (Pubitemid 39119736)
23. Benign and malignant breast tissue classification using trace elements concentration determined by X ray fluorescence. Silva AR, Silva MP, Poletti ME, Histopathology 2010 57 28 28
24. The evaluation of biologically important trace metals in liver, kidney and breast tissue. Al-Ebraheem A, Farquharson MJ, Ryan E, Appl Radiat Isot 2009 67 3 470 474 10.1016/j.apradiso.2008.06.018 18675548
25. Study of trace element concentrations in human tissues by EDXRF spectrometry. Carvalho ML, Brito J, Barreiros MA, X-Ray Spectrom 1998 27 3 198 204 10.1002/(SICI)1097-4539(199805/06)27:3<198::AID-XRS265>3.0.CO;2-B
26. Measurement of K, Fe, Cu and Zn levels in secondary colorectal liver cancer and surrounding normal liver tissue, and their potential as a tissue classifier. Farquharson MJ, Al-Ebraheem A, Theodorakou C, Ryan E, Bradley DA, Gurusamy K, Davidson B, X-Ray Spectrom 2009 38 2 81 88 10.1002/xrs.1121
27. X-ray fluorescence and energy dispersive x-ray diffraction for the quantification of elemental concentrations in breast tissue. Geraki K, Farquharson MJ, Bradley DA, Phys Med Biol 2004 49 1 99 110 10.1088/0031-9155/49/ 1/007 14971775 (Pubitemid 38100625)
28. Study of Br, Zn, Cu and Fe concentrations in healthy and cancer breast tissues by TXRF. Magalhaes T, Becker M, Carvalho ML, von Bohlen A, 12th International Conference on Total Reflection X-Ray Fluorescence Analysis and Related Methods: Jun 18-22 2007 Pergamon-Elsevier Science Ltd, Trento, ITALY 2007 1473 1479
29. Trace elemental correlation study in malignant and normal breast tissue by PIXE technique. Raju GJN, Sarita P, Kumar MR, Murty G, Reddy BS, Lakshminarayana S, Vijayan V, Lakshmi P, Gavarasana S, Reddy SB, Nuclear Instruments & Methods in Physics Research Section B-Beam Interactions with Materials and Atoms 2006 247 2 361 367 10.1016/j.nimb.2006.02.007 22667655
30. Comparison of some trace elements concentration in blood, tumor free breast and tumor tissues of women with benign and malignant breast lesions: An Indian study. Siddiqui MKJ, Jyoti, Singh S, Mehrotra PK, Singh K, Sarangi R, Environment International 2006 32 5 630 637 10.1016/j.envint.2006.02.002 16580070 (Pubitemid 44251080)
31. Trace elements in human cancerous and healthy tissues: A comparative study by EDXRF, TXRF, synchrotron radiation and PIXE. Carvalho ML, Magalhaes T, Becker M, von Bohlen A, Spectroc Acta Pt B-Atom Spectr 2007 62 1004 1011 10.1016/j.sab.2007.03.030 (Pubitemid 47405113)
32. Study of selected trace elements in cancerous and non-cancerous human breast tissues from Sudanese subjects using instrumental neutron activation analysis. Ebrahim AM, Eltayeb MAH, Shaat MK, Mohmed MA, Eltayeb EA, Ahmed AY, Sci Total Environ 2007 383 52 58 10.1016/j.scitotenv.2007.04.047 17570463 (Pubitemid 47031292)
33. Concentrations of Fe, Cu and Zn in breast tissue: a synchrotron XRF study. Geraki K, Farquharson MJ, Bradley DA, Phys Med Biol 2002 47 13 2327 2339 10.1088/0031-9155/47/13/310 12164590 (Pubitemid 34812209)
34. Trace element concentration distributions in breast, lung and colon tissues. Majewska U, Banas D, Braziewicz J, Gozdz S, Kubala-Kukus A, Kucharzewski M, Phys Med Biol 2007 52 13 3895 3911 10.1088/0031-9155/52/13/016 17664584 (Pubitemid 46908602)
35. Multielemental determination in breast cancerous and non-cancerous biopsies by inductively coupled plasma-mass spectrometry following small volume microwave-assisted digestion. Millos J, Costas-Rodriguez M, Lavilla I, Bendicho C, Anal Chim Acta 2008 622 1-2 77 84 18602537
36. An Elemental Correlation Study in Cancerous and Normal Breast-Tissue with Successive Clinical Stages by Neutron-Activation Analysis. Garg AN, Singh V, Weginwar RG, Sagdeo VN, Biological Trace Element Research 1994 46 3 185 202 10.1007/BF02789296 7702976
37. Measurements of X-ray scatter signatures for some tissue-equivalent materials. Poletti ME, Goncalves OD, Mazzaro I, Nuclear Instruments & Methods in Physics Research Section B-Beam Interactions with Materials and Atoms 2004 213 595 598 22667655
38. Recent trends in total reflection X-ray fluorescence spectrometry for biological applications. Szoboszlai N, Polgari Z, Mihucz VG, Zaray G, Anal Chim Acta 2009 633 1 1 18 10.1016/j.aca.2008.11.009 19110110
39. Recent advances in TXRF. Streli C, Appl Spectrosc Rev 2006 41 5 473 489 10.1080/10543400600809318
40. Total Reflection X-Ray-Fluorescence-an Efficient Method for Microanalysis, Trace and Surface-Layer Analysis. Klockenkamper R, Vonbohlen A, J Anal At Spectrom 1992 7 2 273 279 10.1039/ja9920700273
41. Characterization of two medicinal plants by X-ray spectrometry. Zucchi O, Dias AD, Nascimento VF, Salvador MJ, Journal of Trace and Microprobe Techniques 2000 18 3 441 450
42. The localisation and micro-mapping of copper and other trace elements in breast tumours using a synchrotron micro-XRF system. Farquharson MJ, Geraki K, Falkenberg G, Leek R, Harris A, Appl Radiat Isot 2007 65 2 183 188 10.1016/j.apradiso.2006.08.013 17052909 (Pubitemid 44834615)
43. X-ray diffraction microtomography using synchrotron radiation. Barroso RC, Lopes RT, de Jesus EFO, Oliveira LF, Nuclear Instruments & Methods in Physics Research Section a-Accelerators Spectrometers Detectors and Associated Equipment 2001 471 1-2 75 79 22667655
44. X-ray based methods of analysis. Janssens K, Non-Destructive Micro Analysis of Cultural Heritage Materials 2004 42 129 226
45. Tertian R, Claisse M, Principles of quantitative x-ray fluorescence analysis Ed. Heyden, London 1982
46. Atomic spectrometry update-X-ray fluorescence spectrometry. Potts PJ, Ellis AT, Kregsamer P, Streli C, Vanhoof C, West M, Wobrauschek P, J Anal At Spectrom 2006 21 10 1076 1107 10.1039/b611269m (Pubitemid 44462636)
47. Pszonicki L, Hanna AN: Report on the Intercomparison V-10 of the Determination of Trace Elements in Hay Powder IAEA, In. Vienna 1985
48. An introduction to ROC analysis. Fawcett T, Pattern Recognit Lett 2006 27 8 861 874 10.1016/j.patrec.2005.10.010
49. Performance of fluorescence methods, radiographic examination and ICDAS II on occlusal surfaces in vitro. Rodrigues JA, Hug I, Diniz MB, Lussi A, Caries Research 2008 42 4 297 304 10.1159/000148162 18663299
50. Receiver operating characteristic curves and their use in radiology. Obuchowski NA, Radiology 2003 229 1 3 8 10.1148/radiol.2291010898 14519861 (Pubitemid 37152094)
51. Factors influencing the effect of age on prognosis in breast cancer: population based study. Kroman N, Jensen MB, Wohlfahrt J, Mouridsen HT, Andersen PK, Melbye M, Br Med J 2000 320 7233 474 478 10.1136/bmj.320.7233.474 (Pubitemid 30173116)
52. Prognostic impact of BRCA1 immunohistochemistry expression in sporadic breast carcinomas. Ribeiro-Silva A, Garcia SB, Chahud F, Zucoloto S, Jornal Brasileiro de Patologia e Medicina Laboratorial 2005 41 3 197 203
53. Nonparametric-Estimation from Incomplete Observations. Kaplan EL, Meier P, J Am Stat Assoc 1958 53 282 457 481
54. Statistics notes-Survival probabilities (the Kaplan-Meier method). Bland JM, Altman DG, Br Med J 1998 317 7172 1572 1572 10.1136/bmj.317.7172.1572
55. Dawson-Saunders B, Trapp RG, Basic and clinical biostatistics Appleton & Lange, Conneticut: Norwalk 1994
56. Elevated trace element concentrations in malignant breast tissues. Ng KH, Bradley DA, Looi LM, Br J Radiol 1997 70 832 375 382 9166074 (Pubitemid 27190376)
57. Copper exposure modifies the content and distribution of trace metals in mammalian cultured cells. Tapia L, Suazo M, Hodar C, Cambiazo V, Gonzalez M, BioMetals 2003 16 1 169 174 10.1023/A:1020766932605 12572676 (Pubitemid 36140226)
58. The role of iron in cell cycle progression and the proliferation of neoplastic cells. Le NTV, Richardson DR, Biochim Biophys Acta-Rev Cancer 2002 1603 1 31 46 (Pubitemid 35257983)
59. Structure and composition of microcalcifications in benign and malignant lesions of the breast: Study by light microscopy, transmission and scanning electron microscopy, microprobe analysis, and X-ray diffraction. Frappart L, Boudeulle M, Boumendil J, Lin HC, Martinon I, Palayer C, Mallet-Guy Y, Raudrant D, Bremond A, Rochet Y, et al. Hum Pathol 1984 15 9 880 889 10.1016/S0046- 8177(84)80150-1 6469237 (Pubitemid 15125696)
60. Inhibition of Angiogenesis and Tumor-Growth in the Brain-Suppression of Endothelial-Cell Turnover by Penicillamine and the Depletion of Copper, an Angiogenic Cofactor. Brem SS, Zagzag D, Tsanaclis AMC, Gately S, Elkouby MP, Brien SE, Am J Pathol 1990 137 5 1121 1142 1700617
61. New relationships between breast microcalcifications and cancer. Baker R, Rogers KD, Shepherd N, Stone N, Br J Cancer 2010 103 7 1034 1039 10.1038/sj.bjc.6605873 20842116
62. Identifying microcalcifications in benign and malignant breast lesions by probing differences in their chemical composition using Raman spectroscopy. Haka AS, Shafer-Peltier KE, Fitzmaurice M, Crowe J, Dasari RR, Feld MS, Cancer Res 2002 62 18 5375 5380 12235010 (Pubitemid 35024616)
63. Expression of acidic fibroblast growth factor (aFGF) and fibroblast growth factor receptor 4 (FGFR4) in breast fibroadenomas. La Rosa S, Sessa F, Colombo L, Tibiletti MG, Furlan D, Capella C, J Clin Pathol 2001 54 1 37 41 10.1136/jcp.54.1.37 11271786 (Pubitemid 32048293)
64. The role of copper in tumour angiogenesis. Lowndes SA, Harris AL, J Mammary Gland Biol Neoplasia 2005 10 4 299 310 10.1007/s10911-006-9003-7 16924372 (Pubitemid 44256410)
65. Comparative Expression of Fibroblast Growth-Factor Messenger-Rnas in Benign and Malignant Breast Disease. Anandappa SY, Winstanley JHR, Leinster S, Green B, Rudland PS, Barraclough R, Br J Cancer 1994 69 4 772 776 10.1038/bjc.1994.146 7511406 (Pubitemid 24112704)
66. Expression of Fgf and Fgf Receptor Genes in Human Breast-Cancer. Penaultllorca F, Bertucci F, Adelaide J, Parc P, Coulier F, Jacquemier J, Birnbaum D, Delapeyriere O, Int J Cancer 1995 61 2 170 176 10.1002/ijc. 2910610205 7705943
67. The expression and localization of fibroblast growth factor-1 (FGF-1) and FGF receptor-1 (FGFR-1) in human breast cancer. Yoshimura N, Sano H, Hashiramoto A, Yamada R, Nakajima H, Kondo M, Oka T, Clin Immunol Immunopathol 1998 89 1 28 34 10.1006/clin.1998.4551 9756721 (Pubitemid 28457883)
68. Human endothelial gelatinases and angiogenesis. Nguyen M, Arkell J, Jackson CJ, Int J Biochem Cell Biol 2001 33 10 960 970 10.1016/S1357-2725(01) 00007-3 11470230 (Pubitemid 32706688)
69. Comparison of plasma matrix metalloproteases 2, 3, 9 in breast carcinomas and fibroadenomas. Solai F, Nardo T, Patrizi G, Annessi M, Santulli M, Amabile MI, Vasaturo F, G Chir 2010 31 8-9 365 367 20843437
70. Conover W, Practical Nonparametric Statistic John Whiley & Sons, New York 1980
71. Immunohistochemical determination of oestrogen receptor: Comparison of different methods of assessment of staining and correlation with clinical outcome of breast cancer patients. Barnes DM, Harris WH, Smith P, Millis RR, Rubens RD, Br J Cancer 1996 74 9 1445 1451 10.1038/bjc.1996.563 8912543 (Pubitemid 26370738)
72. The importance of prognostic factors in premenopausal women with breast cancer. Finek J, Holubec L, Topolcan O, Elgrova L, Skalova A, Pecen L, Anticancer Research 2007 27 4A 1893 1896 17649790 (Pubitemid 46954693)
73. Relationship among Outcome, Stage of Disease, and Histologic Grade for 22,616 Cases of Breast-Cancer-the Basis for a Prognostic Index. Henson DE, Ries L, Freedman LS, Carriaga M, Cancer 1991 68 10 2142 2149 10.1002/1097- 0142(19911115)68:10<2142::AID-CNCR2820681010>3.0.CO;2-D 1913453
74. An overview of prognostic factors for long-term survivors of breast cancer. Soerjomataram I, Louwman MWJ, Ribot JG, Roukema JA, Coebergh JWW, Breast Cancer Res Treat 2008 107 3 309 330 10.1007/s10549-007-9556-1 17377838 (Pubitemid 351172108)
75. Prognostic significance of number and level of axillary node metastases in breast cancer. Veronesi U, Galimberti V, Zurrida S, Merson M, Greco M, Luini A, Breast 1993 2 4 224 228 10.1016/0960-9776(93)90004-Y (Pubitemid 24003491)
76. Copper deficiency induced by tetrathiomolybdate suppresses tumor growth and angiogenesis. Pan Q, Kleer CG, van Golen KL, Irani J, Bottema KM, Bias C, De Carvalho M, Mesri EA, Robins DM, Dick RD, et al. Cancer Res 2002 62 17 4854 4859 12208730 (Pubitemid 34984403)